Immune Hemolytic anemia.
Immune hemolytic anemia is an acquired anemia resulting from the premature destruction of red cells caused by the presence of antibody and/or complement on the red cell surface. The Coombs test, modified and improved, remains the mainstay of diagnosis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000373:Agglutinins; D000744:Anemia, Hemolytic, Autoimmune / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D000818:Animals; D001323:Autoantibodies; D003080:Cold Temperature; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006168:Guinea Pigs; D006358:Hot Temperature; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D013156:Splenectomy; D013577:Syndrome
D000305:Adrenal Cortex Hormones; D000373:Agglutinins; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D005492:Folic Acid